Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

18-40 GHz High Frequency Power Amplifier

Active

75F40126Q133599Federal

Response Deadline06/18/2026, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract solicitation 75F40126Q133599 issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services is for the procurement of an 18-40 GHz High Frequency Power Amplifier. This combined synopsis/solicitation was posted on June 11, 2026, with a response deadline of June 18, 2026, at 6:00 PM. The procurement is designated as a Total Small Business Set-Aside under FAR 19.5 and falls under NAICS code 334516, which covers communications equipment manufacturing. The office issuing the contract is located in Rockville, Maryland, while the performance of work is specified for Silver Spring, Maryland. Interested small business vendors are invited to respond before the deadline to be considered. The primary point of contact for this solicitation is Howard Nesmith, who can be reached via email or phone. This opportunity is aimed at supporting high-frequency power amplification technology needs within the agency's operational framework.

General Info

FDA seeks small business for 18-40 GHz High Frequency Power Amplifier, response by June 18, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

SBA

Documents

(1)

Solicitation 75F40126Q133599 - High Frequency Power Amplifier RFQ

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseCombined Synopsis

PostedJun 11

Combined Synopsis

Response DeadlineJun 18

Submission deadline

Response Deadline

06/18/2026, 06:00:00 PM UTCin 1 day

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs

Contacts1 person available

OfficeRockville, MD, 20852, USA

Organization / Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Office AddressRockville, MD, 20852, USA

Contacts

Howard Nesmith

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

See Attached Combined Synopsis/Solicitation 75F40126Q133599

Similar Contracts

INDICATOR, POSITIONThe contract pertains to the procurement of a single unit of an Indicator, Position, identified by NSN/Part Number 6610-01-554-8225. This solicitation, issued by the Defense Logistics Agency under the Department of Defense, is designated by the solicitation number SPE4A5-26-T-246F and was posted on June 16, 2026. Interested parties were given until June 24, 2026, to respond to the solicitation. The contract is a federal solicitation, though no details are provided regarding set-aside status or specific NAICS codes. The contract request originates from the Defense Logistics Agency, a federal organization responsible for logistics and supply chain management for the Department of Defense. The place of performance and office address details are unspecified, and no point of contact information is listed. This procurement involves a single purchase request for one indicator position, indicating a focused acquisition likely aimed at meeting a specific operational or inventory need within the federal defense supply system.

Defense Logistics Agency

POSTED

about 8 hours ago

DEADLINE

BATTERY, ANALYZER, REThis contract pertains to the procurement of 46 units of a battery analyzer, specifically identified by the NSN/Part Number 6630-01-526-4098. The solicitation, issued by the Defense Logistics Agency under the Department of Defense, is aimed at fulfilling purchase request number 7017173211. The solicitation was officially posted on June 16, 2026, with a submission deadline set for June 23, 2026. The contract is classified as a federal solicitation without any specified set-aside type or NAICS code. While detailed location information for the office and place of performance is not provided, it is clear that the procurement is managed within the United States. The Defense Logistics Agency is responsible for overseeing the solicitation process, and interested parties could access the full request for quotations through the designated DLA web portal.

Defense Logistics Agency

POSTED

about 8 hours ago

DEADLINE

Protective Clothing Blood Penetration Resistance TesterThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is conducting a market research effort to identify small businesses capable of supplying a Protective Clothing Blood Penetration Resistance Tester. This device is intended to automate and improve the testing of level 4 medical gowns for viral penetration resistance, significantly reducing manual testing time while enhancing consistency and repeatability. The instrument must meet several technical specifications, including the ability to run four simultaneous tests, automatic timing functions, real-time pressure monitoring, and compliance with ASTM F1670 and ASTM F1671 standards. The system must be new, turn-key, and include all necessary hardware, software, manuals, installation, training, and qualification documentation. Interested firms, particularly small businesses under NAICS code 334516, are invited to submit capability statements by June 23, 2026. Responses should include detailed company information, past performance data, technical compliance evidence, warranty terms, and manufacturing origin to facilitate evaluation under Buy American requirements. The delivery location is the FDA’s Winchester Engineering and Analytical Center in Massachusetts, with delivery expected within 120 days of award. This announcement does not constitute a solicitation or binding contract but serves as an information-gathering step for potential future procurements.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or EqualThe contract solicitation seeks quotations for supplying parts and components compatible with three Nova BioProfile FLEX 2 instruments owned by the FDA’s Center for Drug Evaluation and Research (CDER). The requirement includes parts for two main FLEX2 instruments and an additional external sampling module, each identified by specific serial numbers. The contractor must provide new, unused, and defect-free commercial parts or equivalent consumables that fully function with the instruments in their current configuration, without requiring modifications. Delivered items must maintain at least 75% to 80% of their shelf life, and those requiring special conditions such as refrigeration or flammable item handling must comply with relevant regulations. Only manufacturers or authorized resellers may submit quotes, which are due via email by June 26, 2026. The contract period covers 12 consecutive months from the award date, with performance based at the FDA facility in Silver Spring, Maryland. The procurement process is issued as a combined synopsis/solicitation under commercial item acquisition rules, with no separate solicitation document forthcoming. The solicitation emphasizes strict adherence to delivery schedules and quality standards detailed in the attached Statement of Work. Communication and submission of quotations are managed through the designated FDA point of contact.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

NOI - PCA-NHLBI-07088The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is issuing a non-competitive combined synopsis/solicitation under solicitation number 75N98026Q00630 to procure two complete CD Leycom INCA Pressure-Volume Loop Systems along with associated accessories, disposable catheters, and platinum-level training and support. This procurement supports clinical studies conducted by the National Heart, Lung, and Blood Institute’s Laboratory of Cardiovascular Intervention under an Investigational Device Exemption. The purchase will be awarded as a firm-fixed-price order to CD Leycom BV, the sole worldwide manufacturer of this invasive conductance-catheter-based system, which holds FDA 510(k) market clearance for clinical use in human patients. Due to the unique capabilities of CD Leycom’s system and its regulatory approval status, no other vendor can provide an equivalent product, justifying the non-competitive acquisition approach. This acquisition is conducted under FAR Part 12.603 for streamlined solicitation of commercial products and services and falls below the simplified acquisition threshold. It is issued as a Notice of Intent without plans for full and open competition, referencing authorities including FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901. The applicable NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees; however, this requirement is not set aside for small businesses. The solicitation incorporates provisions effective as of March 13, 2026, per the latest Federal Acquisition Circular. The response deadline is set for June 23, 2026, with point of contact information provided for coordination.

National Institutes Of Health Olao

POSTED

DEADLINE